Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Neuromyelitis optica spectrum disorders with multiple brainstem manifestations: a case report.
Registers of multiple sclerosis in Denmark.
Use of the 2010 McDonald Criteria Can Facilitate Early Diagnosis of Pediatric Multiple Sclerosis in a Predominantly Black Cohort.
A new model of cuprizone-mediated demyelination/remyelination.
Extensive acute axonal damage in pediatric multiple sclerosis lesions.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
GM-CSF promotes migration of human monocytes across the blood brain barrier.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Rotation-invariant multi-contrast non-local means for MS lesion segmentation.
Participant perceptions of a novel physiotherapy approach ("Blue Prescription") for increasing levels of physical activity in people with multiple sclerosis: a qualitative study following intervention.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells.
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
Determinants of on-the-job-barriers in employed persons with multiple sclerosis: The role of disability severity and cognitive indices.
Multiple sclerosis and mitochondrial gene variations: A review.
Non-contraceptive benefits of oral hormonal contraceptives.
A Further TWEAK to Multiple Sclerosis Pathophysiology.
Mechanical energy expenditure of subject with multiple sclerosis engaged in daily activities: a case study.
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
Artificial antigen presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells.
Pannexin1 Channels Are Required for Chemokine-Mediated Migration of CD4+ T Lymphocytes: Role in Inflammation and Experimental Autoimmune Encephalomyelitis.
Glucocorticoid treatment of multiple sclerosis.
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
Pages
« first
‹ previous
…
499
500
501
502
503
504
505
506
507
…
next ›
last »